| Product Code: ETC8274879 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Celiac Disease Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Celiac Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Celiac Disease Market - Industry Life Cycle |
3.4 Mexico Celiac Disease Market - Porter's Five Forces |
3.5 Mexico Celiac Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Mexico Celiac Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Mexico Celiac Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.8 Mexico Celiac Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Celiac Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about celiac disease and gluten-free diets in Mexico |
4.2.2 Growing prevalence of celiac disease in the Mexican population |
4.2.3 Rise in demand for gluten-free products and alternatives in the market |
4.3 Market Restraints |
4.3.1 Limited availability of specialized gluten-free products in the Mexican market |
4.3.2 High cost associated with gluten-free products and treatments |
4.3.3 Lack of government regulations and support for celiac disease management in Mexico |
5 Mexico Celiac Disease Market Trends |
6 Mexico Celiac Disease Market, By Types |
6.1 Mexico Celiac Disease Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Mexico Celiac Disease Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Mexico Celiac Disease Market Revenues & Volume, By Infliximab, 2021- 2031F |
6.1.4 Mexico Celiac Disease Market Revenues & Volume, By Larazotide Acetate, 2021- 2031F |
6.1.5 Mexico Celiac Disease Market Revenues & Volume, By Gluten Free Diet, 2021- 2031F |
6.1.6 Mexico Celiac Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Celiac Disease Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Mexico Celiac Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Mexico Celiac Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 Mexico Celiac Disease Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Mexico Celiac Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Mexico Celiac Disease Market Revenues & Volume, By homecare, 2021- 2031F |
6.3.4 Mexico Celiac Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Celiac Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mexico Celiac Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Mexico Celiac Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Mexico Celiac Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Mexico Celiac Disease Market Import-Export Trade Statistics |
7.1 Mexico Celiac Disease Market Export to Major Countries |
7.2 Mexico Celiac Disease Market Imports from Major Countries |
8 Mexico Celiac Disease Market Key Performance Indicators |
8.1 Percentage increase in the number of diagnosed celiac disease cases in Mexico |
8.2 Number of new gluten-free product launches in the Mexican market |
8.3 Growth in the number of healthcare professionals specializing in celiac disease management in Mexico |
9 Mexico Celiac Disease Market - Opportunity Assessment |
9.1 Mexico Celiac Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Mexico Celiac Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Mexico Celiac Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.4 Mexico Celiac Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Celiac Disease Market - Competitive Landscape |
10.1 Mexico Celiac Disease Market Revenue Share, By Companies, 2024 |
10.2 Mexico Celiac Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here